Literature DB >> 16707098

Upregulation of aspartoacylase activity in the duodenum of obesity induced diabetes mouse: implications on diabetic neuropathy.

Sankar Surendran1, Reuben Matalon, Stephen K Tyring.   

Abstract

Aspartoacylase (ASPA) hydrolyzes N-acetylaspartic acid (NAA) into aspartate and acetate. Normal hydrolysis of NAA is important to maintain healthy neurons. Since enteric neuropathy is one of the events seen in diabetes, whether ASPA activity is affected in diabetic condition is not known. In order to investigate the possibility, ASPA activity was examined in the duodenum and brain of obesity induced diabetes model mouse. Aspartoacylase activity was high in the diabetic mouse duodenum compared to control duodenum. The same result was also observed by immunostaining of the mouse duodenum. The activity of ASPA was found to be elevated in the brain of diabetic mouse compared to the control brain. These data suggest that normal hydrolysis of NAA is affected by ASPA activity seen in the type 2 diabetes model mouse and this change is likely to contribute to neuropathy seen in diabetes, if documented also in patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707098     DOI: 10.1016/j.bbrc.2006.04.179

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Expression and localization of myosin-1d in the developing nervous system.

Authors:  Andrew E Benesh; Jonathan T Fleming; Chin Chiang; Bruce D Carter; Matthew J Tyska
Journal:  Brain Res       Date:  2012-01-08       Impact factor: 3.252

Review 2.  Parkinson's disease: oxidative stress and therapeutic approaches.

Authors:  Sankar Surendran; Srinivasagam Rajasankar
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

3.  Targeted metabolomic analysis identifies increased serum levels of GABA and branched chain amino acids in canine diabetes.

Authors:  Allison L O'Kell; Clive Wasserfall; Joy Guingab-Cagmat; Bobbie-Jo M Webb-Roberston; Mark A Atkinson; Timothy J Garrett
Journal:  Metabolomics       Date:  2021-11-14       Impact factor: 4.290

4.  Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease.

Authors:  Nadine Mersmann; Dmitri Tkachev; Ruth Jelinek; Philipp Thomas Röth; Wiebke Möbius; Torben Ruhwedel; Sabine Rühle; Wolfgang Weber-Fahr; Alexander Sartorius; Matthias Klugmann
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

5.  Assessment of genetically modified oilseed rape 73496 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2012-109).

Authors:  Hanspeter Naegeli; Jean-Louis Bresson; Tamas Dalmay; Ian Crawford Dewhurst; Michelle M Epstein; Leslie George Firbank; Philippe Guerche; Jan Hejatko; Francisco Javier Moreno; Ewen Mullins; Fabien Nogué; Nils Rostoks; Jose Juan Sánchez Serrano; Giovanni Savoini; Eve Veromann; Fabio Veronesi; Michele Ardizzone; Yann Devos; Silvia Federici; Antonio Fernandez Dumont; Andrea Gennaro; Jose Ángel Gómez Ruiz; Franco Maria Neri; Nikoletta Papadopoulou; Konstantinos Paraskevopoulos; Anna Lanzoni
Journal:  EFSA J       Date:  2021-06-17

6.  Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility.

Authors:  Sankar Surendran
Journal:  Mol Biol Rep       Date:  2007-10-18       Impact factor: 2.316

Review 7.  Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions.

Authors:  S S Yarandi; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2014-03-24       Impact factor: 3.598

8.  Aspartoacylase deficiency in the white matter of human immunodeficiency virus encephalitis: novel mechanism in axonal damage.

Authors:  Sankar Surendran; Srinivasagam Rajasankar
Journal:  Patholog Res Int       Date:  2011-09-06

9.  N-acetylaspartate catabolism determines cytosolic acetyl-CoA levels and histone acetylation in brown adipocytes.

Authors:  A Prokesch; H J Pelzmann; A R Pessentheiner; K Huber; C T Madreiter-Sokolowski; A Drougard; M Schittmayer; D Kolb; C Magnes; G Trausinger; W F Graier; R Birner-Gruenberger; J A Pospisilik; J G Bogner-Strauss
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

10.  Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.

Authors:  Georg von Jonquieres; Ziggy H T Spencer; Benjamin D Rowlands; Claudia B Klugmann; Andre Bongers; Anne E Harasta; Kristina E Parley; Jennie Cederholm; Orla Teahan; Russell Pickford; Fabien Delerue; Lars M Ittner; Dominik Fröhlich; Catriona A McLean; Anthony S Don; Miriam Schneider; Gary D Housley; Caroline D Rae; Matthias Klugmann
Journal:  Acta Neuropathol       Date:  2017-11-07       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.